Simplifying clinical use of TCGA molecular subtypes through machine learning models.

Kevin M Boehm1, Francisco Sánchez-Vega2

  • 1Computational Oncology Service, Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA; Halvorsen Center for Computational Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.

Cancer Cell
|January 17, 2025
PubMed
Summary

Researchers developed machine learning models to classify The Cancer Genome Atlas (TCGA) molecular subtypes using genomic features. These validated models are available for use, pending clinical implementation.

Related Concept Videos